As of 2026-03-19, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 67.29 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -63.1%.
The range of the Relative Valuation is 54.05 - 86.24 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 28.0x | 24.0x |
| Forward P/E multiples | 20.8x - 24.6x | 23.4x |
| Fair Price | 54.05 - 86.24 | 67.29 |
| Upside | -70.4% - -52.7% | -63.1% |
| Date | P/E |